Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Jiayu Liang
Affiliation
institute of urology
ORCID
Career Start Year
2016
Papers
63
H Index
13
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
37847513
Genomic and Evolutionary Characterization of Concurrent Intraductal Carcinoma and Adenocarcinoma of the Prostate.
Cancer Res
2024
36376185
The therapeutic efficacy of radical prostatectomy and external beam radiation therapy in patients with different pathological patterns of prostate cancer.
Asian J Surg
2023
37793855
Discovery of a glucocorticoid receptor (GR) activity signature correlates with immune cell infiltration in adrenocortical carcinoma.
J Immunother Cancer
2023
37608295
The multi-omics analyses of acsl1 reveal its translational significance as a tumor microenvironmental and prognostic biomarker in clear cell renal cell carcinoma.
Diagn Pathol
2023
37415738
Mutations in epigenetic regulator <i>KMT2C</i> detected by liquid biopsy are associated with worse survival in prostate cancer patients.
Oncol Res
2023
37404997
Retraction to the prognostic value of the pretreatment lung immune prognostic index in patients with metastatic hormone-sensitive and castration-resistant prostate cancer.
Ann Transl Med
2023
37007568
The prognostic value of the pretreatment lung immune prognostic index in patients with metastatic hormone-sensitive and castration-resistant prostate cancer.
Ann Transl Med
2023
37131267
Genomic and transcriptomic features between primary and paired metastatic fumarate hydratase-deficient renal cell carcinoma.
Genome Med
2023
36907910
Neuroendocrine differentiation predicts the therapeutic efficacy of abiraterone and docetaxel as first-line therapy in metastatic castration-resistant prostate cancer.
J Cancer Res Clin Oncol
2023
36865786
Multidisciplinary Team (MDT) Discussion Improves Overall Survival Outcomes for Metastatic Renal Cell Carcinoma Patients.
J Multidiscip Healthc
2023
34185954
Circulating tumour DNA reveals genetic traits of patients with intraductal carcinoma of the prostate.
BJU Int
2022
35733094
Should preoperative computed tomography be routine examination for cervicofacial space infections?
BMC Infect Dis
2022
35790516
[Application of Broadrick occlusal plane analyzer in the functional and esthetic rehabilitation of a patient with severe dental erosion].
Zhonghua Kou Qiang Yi Xue Za Zhi
2022
36578496
Serum uric acid as a risk factor for rejection after deceased donor kidney transplantation: A mono-institutional analysis of paired kidneys.
Front Immunol
2022
35941663
Integrated multi-omics analyses reveal that BCAM is associated with epigenetic modification and tumor microenvironment subtypes of clear cell renal cell carcinoma.
Clin Epigenetics
2022
36247012
Cuprotosis-related signature predicts overall survival in clear cell renal cell carcinoma.
Front Cell Dev Biol
2022
35969149
The tumor-repressing effect of CYP27A1 on renal cell carcinoma by 27-HC arising from cholesterol metabolism.
FASEB J
2022
35864546
Homologous recombination deficiency (HRD) score in aggressive prostatic adenocarcinoma with or without intraductal carcinoma of the prostate (IDC-P).
BMC Med
2022
36362527
Risk Factors for Maxillary Sinus Pathology after Surgery for Midfacial Fracture: A Multivariate Analysis.
J Clin Med
2022
35992138
Expression of glucocorticoid receptor (GR) and clinical significance in adrenocortical carcinoma.
Front Endocrinol (Lausanne)
2022
36128328
Targeting Krebs-cycle-deficient renal cell carcinoma with Poly ADP-ribose polymerase inhibitors and low-dose alkylating chemotherapy.
Oncotarget
2022
36386587
Macrophage-Specific Cathepsin as a Marker Correlated with Prognosis and Tumor Microenvironmental Characteristics of Clear Cell Renal Cell Carcinoma.
J Inflamm Res
2022
36082136
Chronological Liquid Biopsy Reveals the Impact of Platinum-Based Chemotherapy on a Prostate Cancer Patient's CDK12 Mutation: A Case Report.
Onco Targets Ther
2022
35187953
Efficacy of second-line ICIs combined with TKIs among patients with metastatic renal cell carcinoma: a real-world study.
Immunotherapy
2022
35281080
Integrated Analysis of Energy Metabolism Signature-Identified Distinct Subtypes of Bladder Urothelial Carcinoma.
Front Cell Dev Biol
2022
35275862
Prevalence and Risk Factors for Chronic Maxillary Sinusitis After Surgery for Mid-Facial Fracture: A Cross-Sectional Study.
J Craniofac Surg
2022
35115934
Comparison of Systemic Treatments for Metastatic Castration-Resistant Prostate Cancer After Docetaxel Failure: A Systematic Review and Network Meta-analysis.
Front Pharmacol
2022
33414138
Integrated Molecular Characterization of Fumarate Hydratase-deficient Renal Cell Carcinoma.
Clin Cancer Res
2021
33842369
The Role of CD276 in Cancers.
Front Oncol
2021
33725913
Clinical significance of prognostic nutritional index in renal cell carcinomas.
Medicine (Baltimore)
2021
34975480
Evaluation of the Efficacy of PARP Inhibitors in Metastatic Castration-Resistant Prostate Cancer: A Systematic Review and Meta-Analysis.
Front Pharmacol
2021
34435696
The heterogeneity of intraductal carcinoma of the prostate is associated with different efficacy of standard first-line therapy for patients with metastatic castration-resistant prostate cancer.
Prostate
2021
34489456
Integrated exome and RNA sequencing of TFE3-translocation renal cell carcinoma.
Nat Commun
2021
34445989
Association between preoperative serum albumin and prognosis in patients with adrenocortical carcinoma after primary resection: a retrospective study.
BMC Cancer
2021
34105799
Molecular pathways underlying tissue injuries in the bladder with ketamine cystitis.
FASEB J
2021
33937065
A Nomogram Model to Predict Prognosis of Patients With Genitourinary Sarcoma.
Front Oncol
2021
34318630
Exosomal TUBB3 mRNA expression of metastatic castration-resistant prostate cancer patients: Association with patient outcome under abiraterone.
Cancer Med
2021
34028061
Dynamic multidisciplinary team discussions can improve the prognosis of metastatic castration-resistant prostate cancer patients.
Prostate
2021
34194432
Effect of Donor and Recipient ABH-Secretor Status on ABO-Incompatible Living Donor Kidney Transplantation.
Front Immunol
2021
33279225
Operative intervention for recurrence of adrenocortical carcinoma: A single-center experience.
Surgery
2021
33184944
Overexpression of membranal SLC3A2 regulates the proliferation of oral squamous cancer cells and affects the prognosis of oral cancer patients.
J Oral Pathol Med
2021
32420177
Development of nanotechnology in andrology.
Transl Androl Urol
2020
31786772
The clinical utility of 'GRAS' parameters in stage I-III adrenocortical carcinomas: long-term data from a high-volume institution.
Endocrine
2020
31998416
Clinicopathological and Prognostic Characteristics of CD276 (B7-H3) Expression in Adrenocortical Carcinoma.
Dis Markers
2020
33024233
Risk factors and survival outcomes of metachronous contralateral upper tract urothelial carcinoma.
Sci Rep
2020
30569143
Knockdown of ribosomal protein S15A inhibits human kidney cancer cell growth in vitro and in vivo.
Mol Med Rep
2019
31783819
Expression of FSCN1 and FOXM1 are associated with poor prognosis of adrenocortical carcinoma patients.
BMC Cancer
2019
31004655
Increased expression of miR-155 correlates with abnormal allograft status in solid organ transplant patients and rat kidney transplantation model.
Life Sci
2019
31080125
Re: Catherine H. Marshall, Alexandra O. Sokolova, Andrea L. McNatty, et al. Differential Response to Olaparib Treatment Among Men with Metastatic Castration-resistant Prostate Cancer Harboring BRCA1 or BRCA2 Versus ATM Mutations. Eur Urol 2019;76:452-8.
Eur Urol
2019
29180799
Low-intensity extracorporeal shock wave therapy for erectile dysfunction after radical prostatectomy: a review of preclinical studies.
Int J Impot Res
2018
1 - 50 of 63
Column Actions
Search
Recommended Authors
Yue Yang
Institute of Cancer Prevention and Treatment, Harbin Medical University
Career Start Year
2015
Number of shared co-authors
1
Zitong Zhao
School of Pharmacy, Wannan Medical College
Career Start Year
2012
Number of shared co-authors
0
Jiaxing Lin
Peking University People's Hospital
Career Start Year
2012
Number of shared co-authors
0
Fubo Wang
Center for Genomic and Personalized Medicine, Guangxi Medical University
Career Start Year
2011
Number of shared co-authors
1
Yusuke Goto
Chiba University Graduate School of Medicine
Career Start Year
2011
Number of shared co-authors
0
Lu Ji
West China Hospital, Sichuan University
Career Start Year
2010
Number of shared co-authors
0
Sungyong You
Cedars-Sinai Medical Center
Career Start Year
2008
Number of shared co-authors
1
Shancheng Ren
Shanghai Changzheng Hospital
Career Start Year
2007
Number of shared co-authors
1
Liang Liang
Tangdu Hospital, Fourth Military Medical University
Career Start Year
2006
Number of shared co-authors
0
Song Wu
The Third Affiliated Hospital of Shenzhen University (Luohu Hospital Group)
Career Start Year
2006
Number of shared co-authors
1
Chang Wook Jeong
Seoul National University Hospital, Seoul National University College of Medicine
Career Start Year
2005
Number of shared co-authors
0
Hui Xue
Agricultural Genomics Institute at Shenzhen, Chinese Academy of Agricultural Sciences
Career Start Year
2005
Number of shared co-authors
1
Fan Zhang
Huaihe Hospital of Henan University
Career Start Year
2004
Number of shared co-authors
1
Pavlos Msaouel
The University of Texas MD Anderson Cancer Center
Career Start Year
2004
Number of shared co-authors
2
Xiaojie Bian
Fudan University Shanghai Cancer Center
Career Start Year
2003
Number of shared co-authors
1
Lin Qi
Xiangya Hospital of Central South University
Career Start Year
2003
Number of shared co-authors
0
Wenhua Liang
The First People's Hospital of Zhaoqing
Career Start Year
2003
Number of shared co-authors
0
Jun Hyuk Hong
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year
2002
Number of shared co-authors
0
Seok-Soo Byun
Seoul National University Bundang Hospital
Career Start Year
2002
Number of shared co-authors
0
Byong Chang Jeong
Samsung Medical Center, Sungkyunkwan University School of Medicine
Career Start Year
2001
Number of shared co-authors
0
Yongwei Yu
Changhai Hospital
Career Start Year
2001
Number of shared co-authors
1
Wei Zhang
Children's Hospital, Zhejiang University School of Medicine
Career Start Year
2001
Number of shared co-authors
0
Hyun Moo Lee
Samsung Medical Center, Sungkyunkwan University School of Medicine
Career Start Year
2000
Number of shared co-authors
0
Cheol Kwak
Seoul National University Hospital, Seoul National University College of Medicine
Career Start Year
2000
Number of shared co-authors
0
Seong Il Seo
Samsung Medical Center, Sungkyunkwan University School of Medicine
Career Start Year
1999
Number of shared co-authors
0
Jeong-Won Lee
Samsung Medical Center, Sungkyunkwan University School of Medicine
Career Start Year
1999
Number of shared co-authors
0
Nan Wu
Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University
Career Start Year
1997
Number of shared co-authors
0
Dong Lin
Fujian Medical University Cancer Hospital and Fujian Cancer Hospital
Career Start Year
1996
Number of shared co-authors
1
Sung Tae Kim
Busan Paik Hospital, Inje University
Career Start Year
1996
Number of shared co-authors
0
Choung-Soo Kim
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year
1993
Number of shared co-authors
0
row(s) 1 - 30 of 30
Collaborators
Ranjit S Bindra
Yale University School of Medicine
Co-authored papers
2
Randy Caliliw
David Geffen School of Medicine at university of california los angeles
Co-authored papers
1
Shinji Ohtake
Institute of Urologic Oncology, University of California los angeles
Co-authored papers
1
Jinny van Doorn
Yale University School of Medicine
Co-authored papers
1
Rong-Rong Huang
Stomatology Hospital, Zhejiang University School of Medicine
Co-authored papers
1
Juan C Vasquez
Yale School of Medicine
Co-authored papers
1
Daiki Ueno
Institute of Urologic Oncology, University of California Los Angeles
Co-authored papers
1
Amrita Sule
Yale University
Co-authored papers
1
Paul C Boutros
University of California los angeles
Co-authored papers
1
Ranjini K Sundaram
Yale University
Co-authored papers
1
Karla Boyd
Yale University School of Medicine
Co-authored papers
1
Jing Li
Karmanos Cancer Institute, Wayne State University
Co-authored papers
1
Jack Dodson
University of California los angeles
Co-authored papers
1
Huihui Ye
College of Optical Science and Engineering, Zhejiang University
Co-authored papers
1
Brian Shuch
University of California los angeles
Co-authored papers
1
Xun Bao
Wayne State University School of Medicine, Barbara Ann Karmanos Cancer Institute
Co-authored papers
1
Sam Friedman
Yale University School of Medicine
Co-authored papers
1
1 - 17